معرفی
Professor Gareth Griffiths is a Professor of Clinical Trials and Director of the Southampton Clinical Trials Unit (SCTU) at the University of Southampton. His work focuses on developing and overseeing phase I-III clinical trials and early diagnosis studies across various cancers and diseases, aiming to improve treatment standards in the NHS. He leads multidisciplinary teams to design trials that evaluate new therapies, including small dose-finding studies and large-scale efficacy assessments. His research also includes pioneering early cancer detection methods involving thousands of patients.
Key research interests include clinical trial methodology, oncology, and translational research. He has contributed to over 30 active projects, such as the AGILE platform for rapid evaluation of COVID-19 treatments and the OPTIMATE trial for CNS lymphoma. His leadership in SCTU ensures high-quality trial design and execution, with collaborations spanning academic, governmental, and industry partners like Cancer Research UK and the NIHR.
Notable awards include a 2023 NIHR Doctoral Fellowship. His work emphasizes translating research into clinical practice, with a focus on improving patient outcomes through evidence-based therapies.
Grants and collaborations include NIHR funding, MRC support, and partnerships with organizations like BioNTech and Celldex Therapeutics. His team’s efforts span drug development, diagnostic innovations, and healthcare policy, with a commitment to advancing cancer care globally.
He is affiliated with the Centre for Cancer Immunology, NIHR Southampton Biomedical Research Centre, and the Experimental Cancer Medicine Centre, among others. His research addresses critical gaps in cancer treatment and early detection, driving advancements in clinical oncology and trial methodologies.
